305 related articles for article (PubMed ID: 20560830)
1. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
Kim CK; Callaway Z; Fletcher R; Koh YY
J Asthma; 2010 Jun; 47(5):568-73. PubMed ID: 20560830
[TBL] [Abstract][Full Text] [Related]
2. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.
Kim KW; Lee KE; Kim ES; Song TW; Sohn MH; Kim KE
Lung; 2007; 185(2):97-103. PubMed ID: 17393238
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic cationic protein: is it useful in assessing control of childhood asthma?
Zedan M; Settin A; El-Chennawi F; El-Desouky T; Nasef N; Fouda A
East Mediterr Health J; 2010 Oct; 16(10):1045-9. PubMed ID: 21222420
[TBL] [Abstract][Full Text] [Related]
4. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
Onadeko BO; Khadadah ME; Mustafa HT; Ezeamuzie CI; Marouf R; Khamis A; Sugathan TN
East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
[TBL] [Abstract][Full Text] [Related]
5. Correlation of eosinophil cationic protein with severity of asthma.
Badar A; Saeed W; Hussain MM; Aslam M
J Ayub Med Coll Abbottabad; 2004; 16(3):66-71. PubMed ID: 15631377
[TBL] [Abstract][Full Text] [Related]
6. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
7. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity.
Fujitaka M; Kawaguchi H; Kato Y; Sakura N; Ueda K; Abe Y
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):323-9. PubMed ID: 11289333
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
9. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
10. Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.
Gon Y; Ito R; Hattori T; Hiranuma H; Kumasawa F; Kozu Y; Endo D; Koyama D; Shintani Y; Eriko T; Soda K; Maruoka S; Hashimoto S
Allergy Asthma Proc; 2015; 36(6):e113-20. PubMed ID: 26534742
[TBL] [Abstract][Full Text] [Related]
11. Bronchial responsiveness to methacholine and adenosine 5'-monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein.
Choi SH; Kim DK; Yu J; Yoo Y; Koh YY
Allergy; 2007 Oct; 62(10):1119-24. PubMed ID: 17573858
[TBL] [Abstract][Full Text] [Related]
12. Serum eosinophil cationic protein in children with atopic dermatitis.
Murat-Susić S; Lipozencić J; Zizić V; Husar K; Marinović B
Int J Dermatol; 2006 Oct; 45(10):1156-60. PubMed ID: 17040428
[TBL] [Abstract][Full Text] [Related]
13. Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood.
Joseph-Bowen J; de Klerk N; Holt PG; Sly PD
J Allergy Clin Immunol; 2004 Nov; 114(5):1040-5. PubMed ID: 15536407
[TBL] [Abstract][Full Text] [Related]
14. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.
Kim HS; Kim JH; Seo YM; Chun YH; Yoon JS; Kim HH; Lee JS; Kim JT
Ann Allergy Asthma Immunol; 2017 Nov; 119(5):441-445. PubMed ID: 28866306
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.
Kim CK; Callaway Z; Kim DW; Kita H
J Asthma; 2011 Dec; 48(10):994-1000. PubMed ID: 22022864
[TBL] [Abstract][Full Text] [Related]
17. Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma.
Kim CK; Callaway Z; Park JS; Kwon E
Allergol Int; 2017 Jan; 66(1):70-74. PubMed ID: 27329145
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of eosinophil cationic protein levels with clinical symptoms and laboratory findings of patients with cystic echinococcosis].
Cicioğlu Aridoğan B; Kaya S; Sesli Cetin E; Taş T; Demirci M
Mikrobiyol Bul; 2009 Apr; 43(2):285-92. PubMed ID: 19621614
[TBL] [Abstract][Full Text] [Related]
19. Manifold significance of serum eosinophil cationic protein in asthmatic children.
Zubović I; Rozmanić V; Ahel V; Banac S
Acta Med Croatica; 2002; 56(2):53-6. PubMed ID: 12596625
[TBL] [Abstract][Full Text] [Related]
20. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
